IU Health calls for alternative to Indy 500 with fans to avoid spike in COVID-19 – WISHTV.com

INDIANAPOLIS (WISH) IU Health fears the Indianapolis 500, even with a reduced crowd, could lead to a spike in COVID-19 infections and calls on the race organizers to consider an alternative to a race with fans.

Indianapolis Motor Speedway on July 21 announced attendance for the 104th running of the race on Aug. 23 will be approximately 25% of capacity. Face coverings will be required for all attendees. Ticket sales ended Friday. IMS also presented its nearly 100-page plan with its guidelines and protocols to address the need to control the spread of the coronavirus.

IU Health, though, also notes the other places where gatherings could occur restaurants, bars, accommodations and more as being a concern beyond the track.

Based in Indianapolis, IU Health is the largest network of physicians in Indiana. Its a partner with Indiana University School of Medicine, one of the nations leading medical schools.

Heres the entire statement from IU Health:

We appreciate Indianapolis Motor Speedways detailed plan to safely host the 104th Running of the Indianapolis 500. We have concerns about the risks of infection beyond the scope of the IMS plan, including social gatherings, travel, restaurants, bars, accommodations and other event-related activities. This could lead to a spike in COVID-19 infections as we continue to see cases and hospitalizations increase every day. Until we sustain better control of this virus and its spread, we strongly encourage IMS to consider an alternative to running the Indy 500 with fans in August.

Indianapolis Motor Speedway responded late Wednesday night in an email to WISH-TVs newsroom:

IU Healths viewpoint is inaccurate and premature.

IMS has put together a plan that will serve as a model for the careful and conscientious management of events during this pandemic. It is informed by expert advice and reflects our belief that with carefully considered precautions in place, its not necessary or appropriate to return to shutting down events that are important to our state and city.

Despite attempts by our organization to engage with IU Health leadership, we have not received a single suggestion from IU Health as to how our approach might be improved. In contrast, public health officials from our city and state have engaged with us for months. They have given us numerous suggestions that we have implemented, and they have approved our plans subject to continued review.

We remain open to meaningful input from IU Health that will improve our detailed operational plan as we move closer to Race Day.

Coronavirus restrictions in force for Marion County since July 23 include all bars closed, and restaurants with 50% indoor capacity and outdoor seating with social distancing. Social gatherings including weddings, banquets, parties and club meetings are limited to 50 people. All other forms of gatherings, meetings, or special or seasonal events must be limited to 250 people or fewer, unless the citys Public Health department approves a risk mitigation plan for a special or seasonal event that anticipates more than 250 attendees.

The health networks statement came on the same day Gov. Eric Holcomb extended the Stage 4.5 reopening plan through Aug. 27 because of high seven-day average positivity rates for the coronavirus. On July 22, Holcomb initiated a statewide mask mandate. Indianapolis has been under a mask mandate since July 9.

With updated information from the Indiana Department of Health on July 28, this timeline reflects updated tallies of deaths and positive tests prior to that date.

See more here:

IU Health calls for alternative to Indy 500 with fans to avoid spike in COVID-19 - WISHTV.com

Promising Opportunities in North America and Europe to Propel the Growth of the Alternative Cancer Treatment Market 2018 – 2026 – Market Research…

New Study on the Global Alternative Cancer Treatment Market by PMR

PMR recently published a market study that sheds light on the growth prospects of the global Alternative Cancer Treatment market during the forecast period (20XX-20XX). In addition, a methodical and systematic approach adopted by the analysts while curating the market study ensures that the presented study adds value to the business of our customers. The report provides a thorough evaluation of the latest trends, market drivers, opportunities, and challenges within the global Alternative Cancer Treatment market.

As per the report, the global Alternative Cancer Treatment market is expected to grow at a CAGR of ~XX% during the stipulated timeframe owing to a range of factors including, favorable government policies, and growing awareness related to the Alternative Cancer Treatment , surge in research and development and more.

Request Sample Report @ https://www.persistencemarketresearch.co/samples/23062

Resourceful insights enclosed in the report:

Competitive Outlook

The competitive outlook section provides valuable information related to the different companies operating in the current Alternative Cancer Treatment market landscape. The market share, product portfolio, pricing strategy, sales and distribution channels of each company is discussed in the report.

Request Report Methodology @ https://www.persistencemarketresearch.co/methodology/23062

Regional Assessment

The presented market study touches upon the market scenario in different regions and provides a deep understanding of the influence of micro and macro-economic factors on the prospects of the market in each region.

Key players of alternative cancer treatment market includes Innovative Medicine, LLC, Esperity, Northwest Natural Health Clinic, and many more. The companies in alternative cancer treatment market are increasingly engaged in strategic partnerships, collaborations, mergers and acquisitions to capture a greater pie of market share as the market is in the nascent stage.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report covers exhaustive analysis on:

Regional analysis includes

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

For any queries get in touch with Industry Expert @ https://www.persistencemarketresearch.co/ask-an-expert/23062

The market report addresses the following queries related to the Alternative Cancer Treatment market:

More:

Promising Opportunities in North America and Europe to Propel the Growth of the Alternative Cancer Treatment Market 2018 - 2026 - Market Research...

Coronavirus: Hydroxychloroquine use in NZ studies abandoned due to lack of evidence and Covid-19 cases – Stuff.co.nz

AP

A study found no evidence of benefit from a malaria drug promoted as a treatment for coronavirus. Hydroxychloroquine did not lower the risk of dying or needing a breathing tube in a comparison that involved nearly 1400 consecutive patients in New York.

A New Zealand Covid-19 study looking at the efficacy of weekly prophylactic hydroxychloroquine regimes for high risk frontline healthcare workers has abandoned the use of the controversial drug.

Based on the lack of evidence around the effectiveness of the anti-malaria drug which was controversially promoted by US President Donald Trump and Brazilian President Jair Bolsonaro the study wont move onto recruitment and trials.

The drug, which has been suggested as a possible Covid-19 treatment, is yet to be used in trials in New Zealand. It was to be included in three studies that received funding from the Health Research Council (HRC) and Ministry of Health in April.

Given the rapidly emerging evidence on potential Covid-19 treatments from other international trials, all three trials have adapted significantly and have removed hydroxychloroquine as a candidate for treatment or prevention, the council spokesperson said.

READ MORE:* Study finds hydroxychloroquine ineffective against mild Covid-19 cases* Covid-19: British breakthrough finds cheap drug improves survival rate* Coronavirus: Hydroxychloroquine researchers angry, embarrassed by dodgy studies* Coronavirus: What is hydroxychloroquine and why is New Zealand throwing money at it?

The drug has been at the centre of many global studies. Researchers in the US found it to be ineffective against mild Covid-19 cases, and the World Health Organisation (WHO) withdrew it from its Solidarity Trial after finding it produced little or no reduction in mortality rates of hospitalised cases.

The front line healthcare workers study will be funded until its set-up phase. The remaining $300,000 in funding hasnt been reallocated.

Completing the set-up phase would enable the researchers to be in a position to reinitiate a healthcare worker prophylaxis study in [the] future, should there be a major second wave of Covid-19, or an influenza pandemic, the spokesperson said.

If this were to happen, the study would recommence with an alternative medicine, not hydroxychloroquine.

The small amount of Covid-19 cases in New Zealand has also impacted progress of two other HRC-funded studies REMAP-CAP COVID and ASCOT.

Low case numbers in New Zealand has meant recruitment to the two patient trials has not begun, the spokesperson said.

As such, hydroxychloroquine has not been, and will not be, used in New Zealand Covid-19 patients.

REMAP-CAP COVID is an adaptive study that focuses on critically ill Covid-19 patients requiring intensive care. It is open in New Zealand but hasnt begun recruitment.

ASCOT enrols hospitalised Covid-19 patients who dont need intensive care. It is yet to open and recruit participants. The use of lopinavir/ritonavir, another drug the WHO withdrew from its study, has also been removed.

Ben Margot/AP

Hydroxychloroquine wont be used in any New Zealand studies.

Instead of using hydroxychloroquine, researchers in New Zealand and Australia have pivoted the two existing studies to focus on convalescent plasma.

Convalescent plasma involves transfusing antibodies in the plasma of recovering patients into newly infected patients. This treatment method was previously used during the 2009 influenza pandemic, and SARS and MERS outbreaks.

Over 20,000 patients in the United States have safely received convalescent plasma for Covid-19. While conceptually attractive, we still need clinical trials to demonstrate efficacy for patients with Covid-19, said ASCOT principal investigator, associate professor Steven Tong from Australias Doherty Institute.

The REMAP-CAP COVID study is also evaluating other therapies such as immune-modulation treatments, anti-coagulation strategies, vitamin C, and ventilatory strategies.

"This means that patients within these trials are randomised to treatments that are more likely to be beneficial, while interventions determined to be inferior are discontinued, the HRC spokesperson said.

They explained that both the council and the Ministry of Health see the importance of these studies progressing, especially if community transmission becomes an issue again.

In the absence of a vaccine, the clinical trials provide access to the latest emerging evidence on prophylaxis and treatment.

There are 22 active Covid-19 cases in managed isolation and quarantine facilities. None are receiving hospital-level care.

No confirmed cases have been hospitalised in New Zealand for a considerable amount of time, and over 90 days have passed since there was last evidence of community transmission.

See the original post:

Coronavirus: Hydroxychloroquine use in NZ studies abandoned due to lack of evidence and Covid-19 cases - Stuff.co.nz

Medical Wellness Market Revenue Analysis 2020 by Industry Size, Share, Growth, CAGR and Revenue Overview Forecast to 2026|Top key players Massage…

The report on the global Medical Wellness market discusses the various products and their scope in the market. An overview of the global market from an industrial standpoint is presented. The global Medical Wellness market is split into different market segments and after a thorough analysis, the market share of these different segments is provided from the year 2020 to 2026 while the forecast of the data based on the similar market segmentation is carried out from the year 2020 to 2026. The overview of the global market in relation to other markets and the revenue that can be earned from each is also included in the report. Popular trends that can affect the market growth are identified for the base period from the year 2020 to the year 2026. The data is also predicted after extensive market research for the forecast period from the year 2020 to the year 2026.

The report provides a basic overview of the industry including definitions and classifications. The Medical Wellness Market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Get a Sample Report of this Report @ https://www.reportsandmarkets.com/sample-request/global-medical-wellness-market-size-status-and-forecast-2019-2025?utm_source=thediamondreport&utm_medium=6

Some of the leading players in Medical Wellness include @ Massage Envy,Steiner Leisure Limited,World Gym,Fitness World,Universal Companies,Beauty Farm,VLCC Wellness Center,Nanjing Zhaohui,Edge Systems LLC,HEALING HOTELS OF THE WORLD,Golds Gym International,Bon Vital,Kaya Skin Clinic,The Body Holiday,Kayco Vivid,Arashiyu Japanese Foot Spa,Enrich Hair & Skin,WTS International,Biologique Recherche,Guardian Lifecare

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

Global Medical Wellness Market Report 2020 is a professional and in-depth research report on the worlds major regional market conditions of the Medical Wellness industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).

The report focuses on global major leading industry players providing information such as company profiles, product specification, price, cost, revenue and contact information.

The report firstly introduced the Medical Wellness market basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the worlds main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

Market segment by Type, the product can be split intoComplementary and Alternative MedicineBeauty Care and Anti-AgingPreventative & Personalized Medicine and Public HealthHealthy Eating, Nutrition & Weight LossRejuvenationOther

Market segment by Application, split intoFranchiseCompany Owned Outlets

Market segment by Regions/Countries, this report coversUnited StatesEuropeChinaJapanSoutheast AsiaIndiaCentral & South America

Following key questions are answered through this report:

What are the restraining factors in front of the businesses?

Which factors are driving the Global Medical Wellness Market growth?

What are the recent trends in the Global Medical Wellness Market?

What are the global opportunities for getting new clients rapidly?

What are the key regions for expanding the market globally?

What are the threats and challenges in front of the businesses?

Who are the key players in the Global Medical Wellness Market?

TABLE OF CONTENT:

Get Complete Report @ https://www.reportsandmarkets.com/enquiry/global-medical-wellness-market-size-status-and-forecast-2019-2025?utm_source=thediamondreport&utm_medium=6

About Us:

Reports And Markets is part of the Algoro Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Are you mastering your market? Do you know what the market potential is for your product, who the market players are and what the growth forecast is? We offer standard global, regional or country specific market research studies for almost every market you can imagine.

Contact Us:

Sanjay Jain

Manager Partner Relations & International Marketing

http://www.reportsandmarkets.com

Ph: +1-352-353-0818 (US)

Link:

Medical Wellness Market Revenue Analysis 2020 by Industry Size, Share, Growth, CAGR and Revenue Overview Forecast to 2026|Top key players Massage...

L.A.’s Go-Tos for Virtual Meditation, Breathwork and Sound Baths – Hollywood Reporter

Kerry Washington routinely shares quick yoga sequences and even a breathwork meditation flow with her 5.9 million followers on Instagram. The Little Fires Everywhere actress also often gives a shoutout to her own teachers who conduct wellness classes on IG Live. Across almost every platform, from Instagram (which launched a tool called Guides in mid-May that directs users to well-being content) and Wanderlust TV to the Mind-Body app, yogis, gurus and healers are in high demand to provide virtual sessions in meditation, sound baths and breathwork, practices that date back thousands of years.

"There's more of an adoption of these practices," says filmmaker Liz Goldwyn, founder of digital platform The Sex Ed and a fan of sound baths, which are sessions in which ambient music is played to help reach a meditative state. With so many people spending so much time at home, she continues, "We need to sit in these uncomfortable moments and not push away feelings of anxiety."

Goldwyn, who is teaching herself to play Tibetan singing bowls, also sees these modalities as a way of fueling up for current challenges, including battling social injustice. "Self-care is an act of revolution. To go out and fight and see real change, it's important to have these tools in our arsenal."

Some practitioners are starting to offer in-person sessions, such as L.A.-based writer-director Sebastian Siegel (sebastiansiegel.com), whose two-hour Guided Lucid Dreaming events incorporate sound, breath practice and meditation. (Guests who've been known to attend include Mena Suvari, Mariel Hemingway and Frances Fisher, who are in Siegel's upcoming film Grace and Grit.) Attendance is by referral to these small-group meetings, held outdoors at a private home. Says Siegel, "Any time we are going on an adventure exploring internal terrain is time well spent."

Meditation

GLOBAL TRIBE RETREATS Tom Morley known for his Global Tribe Retreats with co-founder Nina Nazar, held in travel destinations around the world has pivoted to virtual yoga and meditation, with more than 200 live classes conducted in the past few months. "There's an external crisis, and that usually stirs uncertainty and fear," says Morley of an increased interest he's seeing. The guided, live meditation classes are an "excuse to be and sit together" virtually, according to Morley, who is trained in Vipassana and Transcendental Meditation and whose students include an Oscar-winning actress. "Some people bring a glass of wine with them, and we all chat before and after." $29 weekly subscription; globaltriberetreats.com

METTAGROUP "In 1968, The Beatles' White Album came out and everybody was examining the idea of Transcendental Meditation," says George Haas, founder of Mettagroup, describing the awakening he believes brought meditation to the American consciousness. Haas studied meditation with renowned teacher Shinzen Young, worked as a film director and writer, and began leading his own classes in 2000. Now presented on Patreon, offerings range from hourlong sessions and daylong workshops to a six-month course to peel back layers of anxiety and trauma. The Buddhist meditation practice takes students through the tenets of Metta (loving-kindness) and Vipassana (insight) meditation once they've mastered the basics of attention training to quiet the mind. Later this year, Haas, in partnership with singer-songwriter Sia, will open the I Love You Keep Going Center in Van Nuys, with a yearlong attachment-repair program and community library. $20 suggested, per class; mettagroup.org

UNPLUG MEDITATION Suze Yalof Schwartz opened Unplug Meditation in 2014, seeking to fill a void in L.A.'s vibrant wellness market. "There were no drop-in meditation studios that were secular, modern and clean like an art gallery," says the former fashion editor. When California's lockdown went into effect this spring, Schwartz and her team quickly launched live-streamed classes. Apple recently helped redesign the Unplug Meditation app, which features one-minute to one-hour classes from a global roster of carefully vetted experts in practices including sound healing, sleep training and stress management. Among the teachers is Olivia Rosewood, who learned meditation from George Harrison and worked with mystic Eckhart Tolle. "Right now people need to feel calm, present and productive," says Schwartz. $24 per class; unplug.com

Breathwork

BREATHE WITH RAE LO A doula and reiki master, Raegan Loston, of Breathe With Rae Lo, sees breath as a tool for everyone. "It's one of the few involuntary functions that we can influence," she says. "It is a healing function that can transform our lives moment to moment." During her video classes, she guides students to embark on a rhythmic breath pattern with music and then transition to passive breath. Loston, who also teaches at Unplug Meditation, plays chimes to close the session. "It's like a wave that allows them to acknowledge where they are," she says. "You can harness your power to influence change in your life and go on with the day." $185 for private lessons; $24 per class through Unplug; breathewithraelo.com

SCOTT SCHWENK "Breath goes right into the nervous system. Do strong work with the breath, and you will have a shift," says Scott Schwenk, the creator of Ecstatic Breathwork, whose path has included becoming a reiki master before the age of 22, living in a yoga ashram, and working at Innovative Artists and CAA. His technique is a series of specific, simple breathing exercises intended to remove emotional blockages. "Scott is an extremely intuitive teacher," says actress Alyssa Diaz (Narcos: Mexico, The Rookie), who completed Schwenk's teacher certification program in October. She now shares breathwork techniques with her Instagram followers (@alydiaz) on what she calls the "Wind Down," along with her fiance, Grammy-nominated musician Gustavo Galindo, who does sound baths during the sessions. "It felt like a bolt of lightning went through my body, a shift and connection to myself that I hadn't had." Schwenk offers private Zoom sessions, as well as classes on the digital platforms Livekick ($15 per class) and Wanderlust TV ($17.99 per month). scottschwenk.com

Sound Baths

SOULSTROLOGY SOUNDBATHS "The ancient Greeks used sound as a healing tool to aid digestion, help calm the mind and assist with better sleep. Tibetan singing bowls have been used in temples by monks for centuries," explains Ambi Kavanagh, of Soulstrology Soundbaths and Alchemy With Ambi, who adds that the benefits also can include slowing down brain waves and helping calm the nervous system. A former entertainment lawyer, she began learning to play gongs and singing bowls in 2012 with Jamie Bechtold, one of the city's sound bath pioneers (whose GongPlay SoundLab in Eagle Rock is now closed because of COVID-19 regulations). Last year, she kicked off Goop's health summit in L.A. Her sessions boast a blend of astrology and sound healing. $18 monthly subscription; soulstrology.com and alchemywithambi.com

ROXIE SARHANGI "My sound healing sessions are heart-focused and connect the mind, body and soul," says Roxie Sarhangi, resident sound healer at 1 Hotel West Hollywood. Since her certification in 2018, Sarhangi has conducted hypnotic, soothing sessions which include a guided meditation and sound from seven crystal bowls, a symphonic gong, ocean drum, koshi chimes and Tibetan bowls that have earned her a loyal following. She's added virtual workshops (which mix sound healing, breathwork and poetry by such revered writers as Rumi and Hafez) for well-being as people cope with the ongoing pandemic. $20 per virtual class; roxiesoundhealing.com

Restorative Movement

ALIGNED LIFE STUDIO Lauren Roxburghs mind-body-spirit approach has made her one of the most sought-after wellness experts in the country. Her long list of celebrity clients includes Jordana Brewster, Emmy Rossum and Sofia Bush. Early in her career, she trained star athletes such as LeBron James and Landon Donovan. The best-selling author of two books (dubbed The Body Whisperer by Goop) has racked up accolades and certifications in structural integration and pilates in addition to her degrees in nutrition and exercise physiology. Yet it was her explorations throughout her 20s, following the work of Deepak Chopra and Andrew Weil, and studying reiki and rolfing, that created the foundation for her expertise on fascia, the casing of connective tissue that surrounds every organ and blood vessel in the body. For decades, alternative medicine practitioners have believed that fascia not only can harden and cause pain, but also store deep-rooted trauma, stress and emotional blockages.

My mom was diagnosed with breast cancer when I was 16, says Roxburgh. The experience put me on this path of wanting to learn what wellbeing truly meant. Streaming in 50 countries, Roxburghs Aligned Life holistic method and studio are a powerhouse program which includes her signature foam-roller workouts, live streaming classes and multiweek challenges, on- and offline coaching and support groups, nutrition, and meditation. She launched the virtual Aligned Life Studio in 2013, together with her husband, Emmy-nominated documentary producer Gus Roxburgh.

Every session begins with a body scan and check-in, neuromuscular self-assessment, and dropping into a calmer state. The whole point is taking time to move, says Roxburgh. Movement becomes meditation slow, methodical and using the breath. We close with meditation, clearing and intention imparting a new sense of calm, new sense of lightness as well as weight loss, improved posture, flexibility, and better pleasure in bed. Most people who go on this journey find ease, freedom and flow. $29 a month/$299 a year;laurenroxburgh.com.

***

Pandemic Mantras and Other Meditations

Feeling COVID-19 fears? Sad about social injustice? Top wellness practitioners offer these recommended sayings

1. "Oh soul, you worry too much. You have seen your own strength. You have seen your own beauty. You have seen your golden wings. Of anything less, why do you worry? You are in truth the soul, of the soul, of the soul." a quote from Persian poet Rumi favored in sessions by sound healer Roxie Sarhangi

2. "Sometimes, we look around and think, well, if everyone else is doing it, why not me? But thats the wrong question to ask, especially if what we want is to live in a better, more just world. The stronger question is: If everyone did what Im thinking of doing, would the world be a better place? If yes, then thats our cue to act." Unplug meditation teacher Light Watkins, who offers daily insights on Instagram (@lightwatkins), where he raises funds for COVID-19 and Black Lives Matter charities

3. "Feel the breath as it flows inward toward the ancestral knowing of survival and protection. Lean in and surrender into any grief and anger. Inhale all that is nurturing and exhale all that no longer serves you. Release. Let go." Jylani Maat Brown, mindfulness practitioner at Unplug

A version of this story first appeared in the July 31 issue of The Hollywood Reporter magazine. Click here to subscribe.

Visit link:

L.A.'s Go-Tos for Virtual Meditation, Breathwork and Sound Baths - Hollywood Reporter

Lam Tian Xings Anthem of the Calamus is an ode to Hong Kongs resilient spirit – Lifestyle Asia

When the Taiwanese writer Gu Yue waxed poetic about Lams lotus paintings in his 2014 essay Tian Xing Fantasia, the passage started off with the verse I am the lotus, and the lotus is me the perfect representation of how artist Lam Tian Xing said he has come to see his career.

Born in Fujian Province in 1963, Lam grew up near the Lotus Peak (or Lianhua Feng), located in the scenic Wuyi Mountains, best known for being an ancient tea-growing region. You could say the presence of the mountain foreshadowed his artistic career (according to him, it definitely inspired part of it) when he would dedicate more than a decade to studying the plant that is heavily symbolic in Chinese tradition and Buddhist teachings, often seen as a sign of resilience.

In 2019, however, Lam made the decision to switch his focus to the tall, grassy calamus plant (the changp in Chinese). Sitting in the basement of the Illuminati Fine Art Gallery on Hollywood Road, he recounted what his new exhibition Anthem of Calamus at the gallery meant to him.

His paintings, known to be combinations of Eastern and Western painting techniques and styles, have depicted flowers, nature as well as the concrete jungles of modern civilisations. His past inspirations have ranged from classical painters such as Bada Shanren in the Ming Dynasty to Zhou Sicong in the 20th Century. However, he noted that no artist he had seen had focused on the calamus as a key subject like in his Anthem series.

For Lam, and as for many Chinese people, the calamus is a symbol of healing. It has long been used in traditional Chinese medicine to remove phlegm and dampness and particularly blockages in the heart, a belief also shared in Ayurvedic medicine. In ancient Chinese culture, the plant was also seen as an ingredient to promote spiritual enlightenment and longevity.

In western medicine, the root is recognised for its ability to soothe upset stomachs and an assortment of digestive ailments, while modern research has also promoted the use of the species for mental and emotional ailments, such as depression and anxiety.

Describing it as a sword, Lam felt it had the ability to bless the people of Hong Kong during difficult times, and, whether as a physical or symbolic salve, it could help fight the pain and frustration found in current society.

Whenever people mentioned Lam Tian Xing they think of the lotus and when they think of the lotus, they think of Lam Tian Xing, he said when asked about the change in his artistic focus. When you reach a certain point, [its] time for a change. The calamus that is actually a plant that grows near the lotus. When you see the lotus, you see the calamus as well. So it is my expression of admiration to the lotus as well as the calamus itself.

From the start of his series in early 2019, the pieces focus on the individual blades of the plant. In some of his paintings, they are depicted in neon orange, cutting through equally vibrant backgrounds, or in black against more monochrome palettes of stormy grey. There appears to be an urgency of purpose with which the plant bursts forward. While painting this series, he noted certain differences in the way he depicted the calamus. He mentioned how in paintings like Admire (above), he found himself working the lotus into the background. He had just switched and his old muse was very much still a part of his art.

However, as Lam progressed, he transitioned from figurative and colourful depictions of the calamus plant to more abstract work. This was accompanied by a shift in perspective zooming in to the micro-details and zooming out to see fields of the plant in an all-encompassing landscape, as seen in Sound of Spring below.

I would observe [the calamus] closely at first, then I would imagine them much further away. So, those brighter yellow spots are actually all calamus like they are growing. Imagination is also very important in observing my art pieces, the artist said.

At times, Lam would study different perspectives of the same plant in his art. In Growth (1) through Growth (4), Lam tried to capture the different angles of the plant itself. Laughing, he compared it to cooking: With one [ingredient], you can cook it in four different styles to have four different flavours.

But as the series progressed, his focus became more philosophical. His favourite painting from the series is a perfect example of this. An ink on paper piece done in black and white, Mystic Thought represents Lams attempt to capture the contrasts in the world around him. For him, its the contrast between the East and the West, yin and yang and Asian culture and the modern world.

Lams last paintings for the series were completed in 2020, just as the CoViD-19 pandemic hit Hong Kong, which further solidified the emotions he felt as he painted, surrounded by clusters of plants. In Lams own words, painting the calamus represents the fear [of the pandemic], the worry and then also the admiration for life and the the hope for a brighter future and that everything will get better.

Illuminati Fine Art is hosting Lam Tian Xings solo exhibition Anthem of Calamus for in person viewing (by advance online reservation only) and on an online viewing room through till 19 September 2020

Visit link:

Lam Tian Xings Anthem of the Calamus is an ode to Hong Kongs resilient spirit - Lifestyle Asia

Novartis Taps Sangamo Zinc Finger Tech for Gene Regulation Therapies – Genetic Engineering & Biotechnology News

Novartis has agreed to license Sangamo Therapeutics zinc finger protein transcription factors (ZFP-TFs) to develop gene regulation therapies for neurodevelopmental disorders that include autism spectrum disorder and intellectual disability, the companies said, through a collaboration that could generate more than $795 million for Sangamo.

Through Sangamos ZFP-TFs, the companies plan over three years to develop treatments addressing three target genes associated with neurodevelopmental disorders, by upregulating the expression of key genes that are inadequately expressed in individuals with certain neurodevelopmental disorders.

The goal is to create new gene regulation therapies that act at the genomic level, moving us beyond the symptom focused treatments of today and toward therapies that can address some of the most challenging neurodevelopmental disorders, Jay Bradner, president of the Novartis Institutes for BioMedical Research, said in a statement. This collaboration with Sangamo is part of our commitment to pioneering the next generation of neurodevelopmental treatments.

Sangamos ZFP-TF genome regulation technology, now delivered via adeno-associated viruses (AAVs), is designed to selectively repress or activate the expression of specific genes to achieve a desired therapeutic effect, at the DNA level.

While AAVs have many advantages that make them well-suited for gene therapy, Novartis says, they also have one disadvantage: They cant carry large genes. The collaboration is designed to enable the companies to target diseases caused by mutations in one copy of a large gene.

The gene for a ZFP-TF is small enough to fit inside an AAV, Ricardo Dolmetsch, head of neuroscience at the Novartis Institutes for BioMedical Research, explained in a post on the companys blog. We can use it to increase the production of a large gene in someone who still has one intact copy of the gene. This dramatically expands the range of diseases that we can potentially target with gene therapy because many diseases are caused by the loss of a single copy of a gene.

Each of Sangamos ZFP-TFs is engineered to bind to a target region of genomic DNA in a highly specific and selective manner. They can be designed to precisely modulate the expression of targeted genes to varying extents. After identifying its target, the ZFP-TF recruits other proteins that help switch genes on or off.

The zinc finger nuclease technology is remarkable, Macrae told GEN in January. Its one of the commonest transcripts in the body. Its natural and human, and its very, very adaptable. The individual units are modular, so one is always able to come up with a solution for any part of the genome.

For its part, Sangamo reasons that it can engineer zinc finger proteins to address virtually any genomic target.

We are building a broad pipeline of wholly owned and partnered programs with the goal to bring our genomic medicines to patients, stated Sangamo CEO Sandy Macrae. In the case of the central nervous system, there are potentially hundreds of neurological disease gene targets that may be addressable by our zinc finger platform.

For Sangamo, the collaboration with Novartis is the second signed this year that focuses on applying ZFP-TFs toward treating neurological disorders. In February, Sangamo launched a potentially more than $2.7 billion partnership to develop and commercialize Sangamo gene regulation therapies. The collaboration included ST-501 for tauopathies including Alzheimers disease, ST-502 for synucleinopathies including Parkinsons disease, a third treatment targeting an undisclosed neuromuscular disease target, and additional treatments for up to nine additional undisclosed neurological disease targets over five years.

In its latest partnership with Novartis, the Swiss pharma giant will have exclusive rights to ZFP-TFs targeting the genes, which are undisclosed, during the three-year collaboration period.

Novartis also has the option to license Sangamos AAVs. Sangamo has agreed to oversee specified research and associated manufacturing activities, all of which will be funded by Novartiswhile Novartis agreed to oversee additional research activities, investigational new drug-enabling studies, clinical development, related regulatory interactions, manufacturing, and global commercialization.

Novartis agreed to pay Sangamo a $75 million upfront license fee within 30 days, plus up to $720 million tied to achieving development and commercial milestonesconsisting of up to $420 million in development milestones and up to $300 million in commercial milestones.

Sangamo is also eligible to receive from Novartis tiered high single-digit to sub-teen double-digit royalties on potential net commercial sales of products arising from the collaboration.

Partnering Sangamos proprietary technology with Novartis deep experience in neuroscience drug development is a powerful combination which expands Sangamos pipeline and allows us to tackle challenging neurodevelopmental conditions, Macrae added.

More here:

Novartis Taps Sangamo Zinc Finger Tech for Gene Regulation Therapies - Genetic Engineering & Biotechnology News

Inside the battle to save the banana – Marketplace

While international spotlight is on the spread of COVID-19, theres another pathogen that scientists arestruggling to contain: tropical race 4, or Panama disease. It doesnt threaten human life but its endangering what the United Nations has deemed the worlds fourth most important food crop: the banana.

A startup in the English city of Norwich is leading the fight to save the banana from this disease.

We are changing the banana genetics to make it more resistant to Panama disease and other diseases, said Gilad Gershon, CEO of Tropic Biosciences, on a recent tour of the companys laboratory.

For 20 years, Panama disease a fungal infection has been spreading across the tropics. Last year it surfaced in Latin America, where most of the worlds bananas for exportare grown. Worldwide, banana exports have been valued at about $13 billion a year

The industry already lives on a very low margin and any disruption of that could have a catastrophiceffect for the industry and the major players in it, Gershon said.

Tropic Biosciences is editing out the genes that make the banana vulnerable to the disease. Gene editing is likely to be met with less resistance from international consumers and regulators than genetic modification, which involves adding DNA of different organisms.

People may be happier about gene editing because it doesnt introduce new genes, said Dr. Dan Bebber, a plant expert at Exeter University.

Nevertheless, the gene editing procedure has fallen foul of the European Unions anti-genetic modification regulations and therefore Tropic Biosciences bananas would be barred from sale in the EU.

Europe accounts for about 30% of global imports. Its a big chunk of the market, conceded Gershon. But this is the reality we have to live with. And theres a very big world outside Europe; 70% of the market is available to us.

Genetic engineering is not the only way to save the banana.Dr. Bebber, who leads an initiative investigating the resilience of banana production and supply, the BananaEx Project, points out that the export trade is particularly vulnerable because it relies on a single strain of the fruit, the Cavendish, which is particularly susceptible to Panama Disease.

We need to think about the diversity of the plants were growing. And there are scientific research groups around the world looking at breeding new types of bananas, as well as the other approaches like gene editing, said Dr. Bebber.

With big money at stake, Tropic Biosciences wont be the only contestant in the race to save the banana. But it will hold its first field trials later this year and plans to have its banana seeds that are resistant to Panama Disease on the market within four years.

As a nonprofit news organization, our future depends on listeners like you who believe in the power of public service journalism.

Your investment in Marketplace helps us remain paywall-free and ensures everyone has access to trustworthy, unbiased news and information, regardless of their ability to pay.

Donate today in any amount to become a Marketplace Investor. Now more than ever, your commitment makes a difference.

Go here to read the rest:

Inside the battle to save the banana - Marketplace

New Cuban drug with very encouraging results against COVID-19 – OnCubaNews

The Cuban drug known so far as CIGB-300 is showing very encouraging results against COVID-19 in its first phase of clinical evaluation, according to the official media.

The antiviral-action drug was designed by the Center for Genetic Engineering and Biotechnology (CIGB) in Havana, and is being studied as part of the research being carried out by Cuban science to confront the pandemic, the BioCubaFarma business group said on Facebook.

Las investigaciones no se detienen en @BioCubaFarma, nuevos medicamentos se evalan para la enfermedad #COVID19. Un

Posted by Biocubafarma onSaturday, August 1, 2020

With previously demonstrated antitumor efficacy, the CIGB-300 is the subject of a controlled clinical trial that started last May in patients positive for SARS-CoV-2, pointed out Cubadebate, which doesnt offer conclusive or preliminary statistics about the trial.

The study seeks to find out the efficacy of this drug against the SARS-CoV-2 coronavirus, following the steps of research carried out with other drugs, which have also had good results.

In total, the CIGB is currently working on 16 lines of research related to the treatment and control of COVID-19, according to Dr. Gerardo Guilln, director of biomedical research at the renowned scientific institution.

Cuba inaugurates plant to produce drug against COVID-19

A few days ago a synthetic peptides production plant was inaugurated at the CIGB, which is already producing a drug successfully used as part of the Cuban medical protocol against coronavirus.

The role of Cuban science, and in particular of its prestigious biotechnology industry, has been fundamental in confronting the epidemic on the island. Several of its products, including Jusvinza or CIGB-258, the recombinant interferon alpha 2bboth CIGB, and Itolizumab, have shown their effectiveness in different stages of the disease.

Original post:

New Cuban drug with very encouraging results against COVID-19 - OnCubaNews

Feeding the World with Genetic Technologies: Technologies and Policies – IDTechEx.com

Genetic Technologies in Agriculture 2020-2030: Forecasts, Markets, Technologies

Genome editing (CRISPR, TALENs, ZFNs), Transgenics (GMOs), Synthetic Biology, and Breeding in Crop Agriculture: Technology and Market Analysis

By Dr Michael Dent

21st century agriculture is facing some major challenges. The global population is set to increase to over 10 billion by 2050, something the UN estimates will require a 70% from today's global food production. At the same, resources are dwindling - the loss of agricultural land stemming from climate change and urbanisation coupled with plateauing crop yields will present major challenges to every nation on Earth.

Genetic technologies in agriculture 2020-2030, a new report from IDTechEx, explores the use of biotechnology as a potential solution to these challenges. The report provides in-depth technical and market insight into the different genetic technologies used in crop agriculture, including transgenics (GMOs), genome editing techniques (CRISPR, TALENs, ZFNs, etc.) and breeding strategies, while also exploring the regulatory and industrial landscapes in which they operate. The report forecasts the future of the industry over the next decade, identifying genome editing technologies as a key growth area.

This is not the first time that world has faced a food crisis This is not the first time that the world has faced a food crisis due to plateauing yields and growing populations. In the 1960s, famine threatened much of Asia, with Paul Ehrlich's 1968 bestseller "The Population Bomb" predicting that famines centred in India would kill hundreds of millions across the following decades.

This bleak future was mostly avoided, largely thanks to the Green Revolution. Using selective breeding, American biologist Norman Borlaug created a high yield strain of wheat that led to more grain per acre, significantly boosting Mexico's agricultural output. Soon, similar strategies were used in India to develop high yield IR8 rice. These selective breeding strategies, alongside advances in fertiliser and mechanisation technologies led to a boom in global food production, with cereal production in Asia doubling between 1970 and 1995.

Selective breeding is just one of many techniques for manipulating the DNA of plants in agriculture to create improved seeds and traits. Over the past few decades, the genetic engineering tools available to scientists has expanded to include methods such as mutagenesis and transgenic breeding, the technique used to develop "genetically modified organisms" (GMOs). However, in recent years, technological advances such as next generation DNA sequencing and gene editing techniques such as TALENs, ZFNs and CRISPR-Cas9 have vastly expanded the capabilities of genetic engineering. This has led to much excitement in the field of agricultural biotechnology, with proponents hoping that modern genetic technologies could help usher in a new Green Revolution of agricultural productivity. Synthetic biology and manipulation of the crop microbiome could open a huge window of opportunities for boosting yields in previously inaccessible ways.

The report assesses the following:

Read the original:

Feeding the World with Genetic Technologies: Technologies and Policies - IDTechEx.com

Bannon Calls for Ban on Nike and Apple Products in the United States – Corporate Crime Reporter

Steve Bannon took to the airwaves yesterday on his daily show War Room: Pandemic and called for a ban on all Nike and Apple products in the United States.

Nike and Apples products should be banned in the United States of America, Bannon said. Woke Nike and Woke Apple are using slave labor in China. Their wokeness is a head fake and a diversion. Their business model is based upon the back breaking forced slave labor costs in China. Thats why their margins are so high. (Apple CEO) Tim Cook is the biggest phony in the world. The guys at Nike are the biggest phonies in the world. Look at the people you are stealing from. . . .Woke Apple that the Republicans and certain people in the Trump administration kowtow to, using slave labor.

Bannon reprimanded Congressional Republicans for arguing that to stand up to China, weve got to keep the concentration of power in these tech companies.

Its exactly the opposite, Bannon said. That is a bald faced lie. The last thing we need is more empowerment of these tech companies. They are not interested in a fight with the Chinese Communist Party. These companies are all in business with the Chinese Communist Party. Its outrageous to use this as an excuse.

In another segment of his show yesterday, Bannon brought up an op-ed that ran in the Wall Street Journal earlier this week titled How to Hold Beijing Accountable for the Coronavirus Why did China cover up the epidemic? The most plausible explanation involves a Wuhan lab, by Jamie Metzl.

Metzl served in the National Security Council and State Department in the Clinton administration. He is a senior fellow of the Atlantic Council, a member of the WHO international advisory committee on human genome editing, and author of Hacking Darwin: Genetic Engineering and the Future of Humanity.

To ensure everyones safety, the WHO and outside investigators must be empowered to explore all relevant questions about the origins of the pandemic without limits, Metzl wrote. This comprehensive forensic investigation must include full access to all of the scientists, biological samples, laboratory records and other materials from the Wuhan virology institutes and other relevant Chinese organizations.

Denying that access should be considered an admission of guilt by Beijing, Metzl concluded.

On his podcast, Bannon read that portion of the op-ed and then said Beijing is not just going to turn over the relevant information.

Give them 72 hours to turn over everything, Bannon said. Then you drop the hammer on them. You sanction the banks. You sanction the individuals. You cut them off from the dollar. The only thing they understand is smash mouth.

See more here:

Bannon Calls for Ban on Nike and Apple Products in the United States - Corporate Crime Reporter

Protein Sequencing Market Updated Business Strategies, Growth and Opportunities|Agilent Technologies – PharmiWeb.com

Pune, Maharashtra, India, July 31 2020 (Wiredrelease) MarketResearch.Biz : The recent report posted via MarketResearch.Biz on Protein Sequencing market offers critical market insights in conjunction with targeted segmentation evaluation. The report examines key using elements which might be anticipated to drive the increase of the market.

Global Protein Sequencing Market Research Report offers crucial data on numerous market situations, for example, ability improvement elements, elements controlling the advancement, market possibilities, and risks to the global market. Also, the report widely facilities round competitive evaluation of Protein Sequencing Market. The competitive evaluation section includes key producers, recent players, providers, market strategies, ability chances, operation panorama, and evaluation of the traits of the Protein Sequencing market. The market consequences are targeted by round the present market scenario. To gauge and expect the competitive scenario on this market. This report will likewise assist all of the producers and speculators to have an advanced comprehension of the investments to recognize wherein the market is heading.

For Better Understanding, Request A Free Pdf Sample Copy Of Protein Sequencing Market Here@ https://marketresearch.biz/report/protein-sequencing-market/request-sample

(***Our FREE SAMPLE COPY of the report offers a quick advent to the studies report outlook, TOC, a listing of tables and figures, an outlook to key players of the market, and comprising key regions.)

Leading players of Protein Sequencing including:

Agilent Technologies Inc, Bioinformatics Solutions Inc, Charles River Laboratories Inc, Proteome Factory AG, Rapid Novor Inc, Selvita SA, SGS SA, Shimadzu Corporation, Thermo Fisher Scientific Inc, Waters Corporation

Segmentation on the Basis of Component: Sample Preparation Products & Services, Protein Sequencing Products, Protein Sequencing Services. Segmentation on the Basis of Technology: Edman Degradation, Mass Spectrometry. Segmentation on the Basis of Application: Biotherapeutics, Genetic Engineering. Segmentation on the Basis of End User: Academic Institutes & Research Centers, Pharmaceutical & Biotechnology Companies

Download Now And Browse Complete Information On The COVID 19 Impact Analysis On Protein Sequencing Market:https://marketresearch.biz/report/protein-sequencing-market/covid-19-impact

Protein Sequencing Report Covers Following Questions:

1. What will the market increase rate, increase momentum of Protein Sequencing market

2. What is the envisioned size of the rising Protein Sequencing market in 2029?

3. Which section is anticipated to account for the most important Protein Sequencing market percentage by 2029?

4. What are sales, revenue, and value evaluation by areas of Protein Sequencing market?

5. What are the market risk, market possibility and market review of the Protein Sequencing market?

6. Who are the distributors, dealers, and buyers of Protein Sequencing market?

Moreover, the report in brief research the overall performance of each historic statistics in conjunction with the current traits. It consists of an entire evaluation of various attributes inclusive of production base, type, and size. This report evaluates the market segmentation in conjunction with the competitive panorama worldwide in addition to the local level. The report additionally discusses approximately the growing want for Protein Sequencing market.

Reasons for Buying this Report

The worldwide Protein Sequencing market report offers a forward-searching attitude on Driving and restraining elements of the market increase.

Ten-year forecast assessed on the premise of how the market is expected to grow

Future evaluation is moreover supplied on how the market is predicted to grow

Past market dynamics of the past years

Helps in know-how the important thing product segments and their future estimations

Focused evaluation of converting competitive dynamics to recognize the procedures utilized by the numerous key players withinside the market

Any Query? Feel Free To Enquire Here: https://marketresearch.biz/report/protein-sequencing-market/#inquiry

Report on Global Protein Sequencing Market 2020 contains of 10 Sections in Table as follows:

Industry Overview of Protein Sequencing: Includes numerous definitions, specs in conjunction with its features, and applicability.

Protein Sequencing Manufacturing Cost & Price Structure Analysis: Raw Material required and their suppliers, price shape evaluation on the subject of production, structural evaluation of promoting price, break-even factor evaluation, and procedure evaluation.

Production Description: Capacity and Commercial Production Date of Protein Sequencing Major Manufacturers in 2020, Manufacturing Plants Distribution, R&D Status, and Technology Source and Raw Materials Sources Analysis.

Global Protein Sequencing Overall Market Overview: Overall Market Analysis starting from Production to Revenue

Global Protein Sequencing segmentation:

By Type: Sales and Factors impacting the increase in sales.

By Application: Consumer evaluation in conjunction with the end-user evaluation.

Analysis of Major Manufacturers of Protein Sequencing across the world: Examination of every Company profiles, picture of the object and details, sales, preceding costs, income, Gross Margin Analysis, Business Region Distribution Analysis

The trend of Protein Sequencing Market: Protein Sequencing Market Trend Analysis, Market Size (Volume and Value) Forecast, Regional Market Trend, Market Trend via way of means of Product Type and Applications.

Browse The Complete TOC of the Report: https://marketresearch.biz/report/protein-sequencing-market/#toc

The Protein Sequencing market report reads pin-direct evaluation for converting extreme dynamics in regards to converting factors that drive or limits market improvement. The report is comprehensively visualized to forecast the market factor of view and possibilities wherein it has an extension to expand in the future. Basically, the report segregates the potential of the market withinside the current and the upcoming opportunities from numerous edges in detail.

About Us:

MarketResearch.Biz is a specialized market research, analytics, and solutions company, offering strategic and tactical support to clients for making well-informed business decisions. We are a team of dedicated and impassioned individuals, who believe strongly in giving our very best to what we do and we never back down from any challenge. The company offers services such as data mining, information management, and revenue enhancement solutions and suggestions. We cater to industries, individuals, and organizations across the globe, and deliver our offerings in the shortest possible turnaround time.

Contact Us:

Mr. Benni Johnson

Prudour Pvt. Ltd.

420 Lexington Avenue,

Suite 300 New York City, NY 10170,

United States

Tel: + 1-347-826-1876

Website: https://marketresearch.biz/

This content has been published by MarketResearch.Biz company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at contact@wiredrelease.com.

Go here to read the rest:

Protein Sequencing Market Updated Business Strategies, Growth and Opportunities|Agilent Technologies - PharmiWeb.com

The Tyranny of Merit: what’s become of the common good? – The London School of Economics and Political Science

Join us for this online public event with Michael Sandel who will be discussing his latest book,The Tyranny of Merit: What's Become of the Common Good?

In this new bookSandel argues that to overcome the polarised politics of our time, we must rethink the attitudes toward success and failure that have accompanied globalisation and rising inequality. Sandel highlights the hubris a meritocracy generates among the winners and the harsh judgement it imposes on those left behind. He offers an alternative way of thinking about success - more attentive to the role of luck in human affairs, more conducive to an ethic of humility, and more hospitable to a politics of the common good.

Michael Sandelteaches political philosophy at Harvard University. His writingson justice, ethics, democracy, and markets--have been translated into 27 languages. His course Justice is the first Harvard course to be made freely available online and on television. It has been viewed by tens of millions of people around the world, including in China, where Sandel was named the most influential foreign figure of the year. (China Newsweek)

Sandels books relate enduring themes of political philosophy to the most vexing moral and civic questions of our time. They includeWhat Money Cant Buy: The Moral Limits of Markets;Justice: Whats the Right Thing to Do?; The Case against Perfection: Ethics in the Age of Genetic Engineering; Public Philosophy: Essays on Morality in Politics; Democracys Discontent: America in Search of a Public Philosophy; andLiberalism and the Limits of Justice.

You can order the book,The Tyranny of Merit: What's Become of the Common Good?, (UK delivery only) from our official LSE Events independent book shop,Pages of Hackney.

Andrs Velasco (@AndresVelasco) is Professor of Public Policy and Dean of the School of Public Policy at the London School of Economics and Political Science.

TheSchool of Public Policy(@LSEPublicPolicy) is an international community where ideas and practice meet. Our approach creates professionals with the ability to analyse, understand and resolve the challenges of contemporary governance.

Twitter Hashtag for this event:#LSESandel

View post:

The Tyranny of Merit: what's become of the common good? - The London School of Economics and Political Science

Draper to Build on its Biosecurity Tool Development for IARPA – Yahoo Finance

The Office of the Director of National Intelligence has contracted with Draper to develop new kinds of detection systems that can identify whether engineered organisms have been created from natural organisms.

CAMBRIDGE, Mass., July 28, 2020 /PRNewswire-PRWeb/ --Advances in gene editing technology and improved access via the web have substantially increased the prevalence of engineered organisms in our world. Benefits range from pest-free crops to reduction in the spread of infectious diseases, but along with these advantages comes a need to identify good bioengineering from the kind that might pose a threat.

To address this challenge, the Office of the Director of National Intelligence (ODNI) has contracted with Draper to develop new kinds of detection systems that can identify whether engineered organisms have been created from natural organisms. Officials at ODNI's Intelligence Advanced Research Projects Activity (IARPA) have awarded Draper a two-year Phase 2 contract under its Finding Engineering-Linked Indicators (FELIX) program, for a total contract value worth $7.8 million.

The award calls for Draper to continue development of two distinct lab-based genetic tests, custom bioinformatics pipelines that contextualize DNA sequencing data, and miniaturized microarray hardware with a specialized design. The devicesmaller than a postage stampallows multiple rounds of genetic tests on any organism, from a broad variety of sources including soil and water. Potential applications include biothreat detection, environmental monitoring and food inspection.

The microarray can be equipped with up to 10,000 surface probes to help identify genetic engineering. The device and associated lab methods combined are sensitive enough to pick out a ratio of a single engineered organism against a complex environmental background containing millions of natural organismsa signal-to-noise ratio that is a significant improvement over current methods.

Kirsty McFarland, molecular microbiologist and Principal Investigator on Draper's FELIX program, says the technologies under development will be able to detect genetic signatures that are not accessible with current technologies. "Current methods for detecting engineered organisms, in soil for example, read only a subset of all the genetic material that's present in the sample, typically through next-generation sequencing. That process inherently misses information and does not reveal important genetic context," she said. She noted that one gram of soil may contain up to one billion microbial genomes.

To accompany each genetic identification system, Draper also developed two custom bioinformatics tools, which include a computational pipeline and visual dashboard that convert lab data into actionable intelligence that users can see on a computer screen.

Draper's FELIX contract is the result of close collaboration between the Synthetic Biology group and Draper's Special Programs Office.

Draper At Draper, we believe exciting things happen when new capabilities are imagined and created. Whether formulating a concept and developing each component to achieve a field-ready prototype or combining existing technologies in new ways, Draper engineers apply multidisciplinary approaches that deliver new capabilities to customers. As a not-for-profit engineering innovation company, Draper focuses on the design, development and deployment of advanced technological solutions for the world's most challenging and important problems. We provide engineering solutions directly to government, industry and academia; work on teams as prime contractor or subcontractor; and participate as a collaborator in consortia. We provide unbiased assessments of technology or systems designed or recommended by other organizationscustom designed, as well as commercial-off-the-shelf. http://www.draper.com

SOURCE Draper

Read the original:

Draper to Build on its Biosecurity Tool Development for IARPA - Yahoo Finance

Halo Infinite should close the ring that is Master Chief and Cortana’s saga – GamesRadar+

Halo Infinite is coming and with it should be the end of Master Chief's 20-year story.

It certainly seems like 343 Industries is teeing Halo Infinite up to be the final chapter in the epic saga that is John-117. The trailer that debuted at the Xbox Games Showcase ends with Chief coming face-to-face with a Banished leader whose monologue implies the Chief's demise: "But here you now stand. This is my last fight. A true test of legends, our story will outlive us both. Set a fire in your heart, Spartan. Bare your fangs, fight hard, die well."

With the news that Halo Infinite is meant to be the last standalone Halo title for a decade, there's nothing left for 343 to do except to kill their darling or in this case, their Master. The blatant throwback to Halo: Combat Evolved in the Halo Infinite box art and the game's nostalgic, sunny graphics hammers home the idea that Halo Infinite will close the loop that is the Halo saga. It's a narrative Halo ring, and this is the final piece.

Here's how all roads point to Halo Infinite closing the door forever on Master Chief, Cortana, and the Halo universe as we know it, and why that's a good thing.

While Halo lore is far more complicated than the gameplay would have you think, it's clear that the epic story has been funnelling us towards a logical conclusion. Let's recap, as it can get a bit convoluted.

Long before the events of Halo: Reach, humans were an advanced, spacefaring species in the running to obtain the Mantle of Responsibility. The Mantle is an ideology before it is an object, the creation of the Precursors (an ancient species responsible for genetically engineering many of the races in the galaxy). It represents the obligation of the most advanced race to protect lesser life forms in the galaxy but the Forerunners, another alien race, believed they were the rightful inheritors of the Mantle, and began a long war that led to them forcing humans to live in a pre-technological state on a planet known as Earth.

The term "Reclaimer" is important here it's used to refer to the species chosen to inherit the Mantle in particular, it refers to humans who carry a special genetic code written in by a Forerunner known as the Librarian. Reclaimers can activate Forerunner technology it's why Master Chief comes damn near close to activating the ring in Halo: Combat Evolved, and why he seems to know his way around the tech despite never having encountered it before. It's also why the Covenant have to kidnap humans to activate Forerunner tech despite believing they deserve the mantle, none of the Covenant races are Reclaimers. Sucks to suck.

The genetic code that Chief contains is also responsible for the creation of other SPARTANs and Cortana's creation - the Librarian planted seeds that led to technological advances like the SPARTAN program and Smart AI. This speaks to the larger picture of the ties that bind Chief and Cortana.

Sacrifice is a common theme in the Halo franchise, though the ultimate sacrifice (giving one's life) has thus far been reserved for characters who aren't Master Chief and Cortana though not for their lack of trying.

In Halo: Reach, every member of Noble Team (save one) sacrifices themselves to ensure humanity can stand against the Covenant. At the end of Halo 3, it appears Chief has sacrificed himself to save humanity, although he obviously ends up surviving. At the end of Halo 4, you control Chief as he desperately claws his way to a nuclear warhead that he detonates with his hands to save humanity. Again, Chief doesn't die, despite being centimeters away from a nuclear explosion - because Cortana sacrifices herself to save him.

By Halo 5, it's clear that Cortana is still alive, though driven to madness by rampancy (a sort of deterioration that advanced AI suffer after being online for more than seven years"), and determined to get her hands on the Mantle of Responsibility, which she claims belongs to AI.

For Halo: Infinite to narratively and thematically close the Halo loop, Chief should sacrifice himself to stop the Banished (and likely Cortana and the Created, a faction of rogue artificial intelligence she founded). But there's arguably an even bigger sacrifice, in John's future Cortana herself, the closest thing this tragic figure has had to a loved one since his brief childhood.

And that may very well be the core of this Halo epic. Master Chief and Cortana's relationship, brought together by destiny, by the genetic gifts bestowed upon humanity by the Precursors.

"We go together," Chief tells Cortana at the end of Halo 4. It's a simple statement that profoundly states his feelings for her. After she sacrifices herself for Chief, a montage plays of their interactions across the series, hammering home the notion that this bond goes beyond a soldier tasked with protecting an AI. She is, after all, the only real thing that gives Chief pathos in the entire series, and that's thanks to 343 deciding to lean into that relationship when they took the Halo helm.

Before that, Chief is merely a faceless super soldier with a pretty solid moral compass, one-lining his way through a franchise in order to save the world and his snarky computer lady. Cortana and Chief are the beating heart of the Halo franchise but I think it's time for that heart to stop.

With the back-to-back fake-outs of Halo 3 and Halo 4, the stage is set for Chief to make the ultimate sacrifice. Cortana is still alive at the end of Halo 5, after having brutally betrayed him in order to continue on her rampage to get her hands on the Mantle. As the Banished leader said in the Halo Infinite trailer, it is indeed time for John-117 to "set a fire" in his heart in order to "die well." But not before he takes Cortana with him.

See the rest here:

Halo Infinite should close the ring that is Master Chief and Cortana's saga - GamesRadar+

Where Did COVID-19 Really Come From? – besacenter.org

Wuhan Institute of Virology main entrance, Wuhan City, Hubei province, China, image via Wikimedia Commons

BESA Center Perspectives Paper No. 1,664, July 28, 2020

EXECUTIVE SUMMARY: The questions of the true genomic origin as well as the direct source of the initial SARS-CoV-2 strain that infected Patient Zero in China, an event that ultimately unleashed COVID-19 on the world to devastating effect, are hotly debated and highly consequential. Both science and intelligence will contribute to uncovering the evidence needed to answer these questions conclusively.

Behind the great challenge of how to deal with the global COVID-19 pandemic are the questions of the viruss true genomic origin and direct source. These questions will likely be answered through synergies between science and intelligence, the combined findings of which will ultimately converge into a critical mass of evidence.

SARS-CoV-2 is the strain of coronavirus that causes COVID-19. According to unofficial reports and taking into account the viruss incubation period, Patient Zero was apparently infected in Wuhan, China in October or November of 2019. However, it was not until December 31, 2019 that the Wuhan Municipal Health Commission issued an alert that there was a cluster of cases of viral pneumonia in Wuhan. At the time, the initial source of the virus was said to have been an unidentified infected animal from the Wuhan wet market. This claim was later abandoned by China.

An alternative possibility is that the viruswhether natural, man-made, or otherwise modifiedleaked from a lab at the Wuhan Institute of Virology (WIV) or another Wuhan-based facility.

In 2015, an article in Journal of Defence Studies profiled the Chinese biological warfare program and noted that the WIV, basically a civilian facility, dealt with certain pathogens, including the SARS virus.In 2019, the WIV was involved in the improper dispatch of highly virulent viruses (not coronaviruses) from Canada to China, which bolstered that case. In January 2020, the WIV was identified as a facility from which SARS-CoV-2 had possibly leaked.

Whether or not the WIVs labs, civilian or otherwise, were holding the COVID-19 virus, it could be an intact natural virus strain. A lab leak might have occurred via an accidentally infected worker, an infected lab animal, or a technical failure.

In February 2020, Maj. Gen. Prof. Wei Chen, a prominent Chinese biological warfare expert affiliated with the militarys Beijing Institute of Biotechnology, was appointed head of the WIV wing, which is at biosafety level 4 (the highest level). In Wuhan, she collaborated with the Wuhan Institute of Biological Products and Wuhan-based academic institutions. Her object was to develop vaccines, anti-sera, and other countermeasures to guard against the spreading COVID-19 virus.

In the US, Prof. Francis Boyle claimed on February 2 that the virus had been held at the WIV as a bioweapon and leaked from its lab. Sen. Tom Cotton amplified the lab virus theory on February 17, when he said the virus might have leaked from the WIV. Concrete evidence beyond the circumstantial was not offered, which discredited the theory.

On the intelligence level, however, evidence was being accumulated that gave credence to the possibility of a Chinese lab leak. On April 5, British intelligence indicated that the features of SARS-CoV-2, as well as the extensive studies conducted in Wuhan on similar coronaviruses, rendered the lab script a credible alternative view. US intelligence officials said there is no evidence the pandemic coronavirus was created in a laboratory as a potential bio-weapon or engineered, but those words do not negate the possibility of a lab leak.

A few days after that statement, nine officials from the current and former US intelligence and national security services who are familiar with the investigations in progress said the possibility that the pandemic was triggered by an accident at a research facility in Wuhan was certainly real and was absolutely under scrutiny at the highest level. Several weeks later, President Trump noted with a high degree of confidence that the outbreak emanated from the WIV, though he added that he could not reveal details.

US Secretary of State Mike Pompeo (who was head of the CIA until April 2018) said that in addition to the WIV, There are multiple labs where the Chinese Communist Party is working on various levels of pathogens. He has also made these statements:

He has also said, however, that The intelligence community is still figuring out precisely where this virus began. We are all trying to figure out the right answer and There are different levels of certainty expressed at different sources of information. Pompeo added that he has no reason to doubt the US intelligence communitys consensus that the virus was not man-made or genetically modified.

A contemporaneous statement from the office of the acting Director of National Intelligence confirmed this, saying the US intelligence community

concurs with the wide scientific consensus that the COVID-19 virus was not a man-made or genetically modified virus. The Community will continue to rigorously examine emerging information and intelligence to determine whether the outbreak began through contact with infected animals (a natural contagion) or if it was the result of an accident at a laboratory in Wuhan.

At about the same time, a preliminary US government analysis compiled from open information said there is no smoking gun to blame the virus on either the Wuhan Institute of Virology or the Wuhan CDC branch, but there is circumstantial evidence to suggest such may be the case while all other possible places have been proven to be highly unlikely.

One US intelligence viewpoint is that there is growing evidence that the virus likely came into being in a Wuhan laboratory, not as a bioweapon but as part of Chinas effort to demonstrate that its ability to identify and combat viruses is equal to or greater than that of the US. Further, a majority of the 17 agencies that provide and analyze intelligence for the US government concurred in May that they believe the pandemic started after the virus leaked from a Wuhan lab, a claim based mostly on circumstantial evidence.

Sen. Tom Cotton, meanwhile, who is a member of the US Senate Select Committee on Intelligence, bolstered his lab leak argument with details based on unclassified general information:

All the evidence at this point points to two labs in Wuhan, while no evidence at all points to the wet market in Wuhan. The fact that they research coronaviruses, that they used bats, that they have a history of bad safety practices, that Patient Zero had no contact with the wet market, all of that is circumstantial evidence to be sure. But in intelligence questions, we rarely get direct or conclusive evidence. So I agree that all of the evidence, albeit circumstantial, points directly at those labs. And if the Chinese Communist Party has evidence to the contrary, they need to bring it forward to the world.

Cotton added, Whether the virus was genetically modified or engineered is a highly technical, scientific question. And the weight of scientific opinion right now [May 5, 2020] says that, no, this was a naturally occurring virus. But a naturally occurring virus can, of course, be present in a laboratory where its being studied.

Statements made afterward by US Assistant to the President Peter Navarro were sharper:

I think personally the virus was spawned in a P4 weapons lab (WIV) The Ground Zero patient in Wuhan was within yards of that P4 lab I think its incumbent on China to prove that it wasnt that lab The Chinese spawned the virus, not created it. That virus was a product of the Chinese Communist Party, and until we get some information about what happened in those labs or what happened in that wet market, we know that the virus was spawned in China. Whether it was purposefully spawned in the Chinese lab is still an open question.

Navarro apparently meant that in a classified military lab of WIV (nominally, and largely in reality, an institute affiliated with the Chinese Academy of Sciences), the Chinese enabled the virus to emerge, whether or not they intended to give rise to the virus that actually came into being. The roles of that lab and the wet market in propelling the initial outbreak remain to be explained. One possibility is that infected animals from the lab were illegally sold in the market. This would fit Navarros description of Patient Zero, who came down with the virus before the market became associated with the contagion.

At any rate, Navarrolike Cottonsaid it is Chinas responsibility to provide evidence of a natural contagion of SARS-CoV-2. As long as China fails to do this, the contagion is to be regarded as unnatural.

In late June, an unclassified report by the US State Department referred to Chinas biological warfare program at large, stating:

The United States does not have sufficient information to determine whether China eliminated its assessed biological warfare program, as required under Article II of the Convention [Chinassubmissions to the convention] have neither documented that offensive program, nor documented that Chinahas eliminated the program or any remaining biological weapons [as required under the accord].

British military and intelligence expert Col. (ret.) Richard Kemp said he had been told by an unnamed insider that there was a very high probability that SARS-CoV-2 was released unintentionally from a Wuhan lab and was a man-made variation. He said he was tipped off about a warfare facility near Wuhan by a senior foreign intelligence source who said analysts strongly suspected Chinas WIV.

Kemp added,

It is very likely to be the case. I was also led to believe governments were very unlikely to come out and say it outright, but that China had been made aware that intelligence agencies had significant evidence. The virus came from an animal that had been involved in testing in the WIV, and had ended up in the wet market. It was believed then and now that an unscrupulous member of staff sold it for personal profit without considering it may be infected. That is how it got out a postulation known to be true but [that] cannot be backed up by absolute evidence.

While this report was highly informative, it has not been verified or refuted.

Australian PM Scott Morrison declined on April 30 to buy into the lab theory, stating that he had not seen anything that suggests that conclusively, while virus emergence from [the] Wuhan wet market appears more likely. Other voices in the Australian government held that it would be unwise to rule out the possibility of the lab scenario. Australian Chair of the Parliamentary Joint Committee on Intelligence and Security Andrew Hastie was diplomatic on the question: I think there are a lot of contentions, and all of them deserve to have a serious consideration. We have to be open-minded about all possibilities.

The specific evidence obtained by the US intelligence community has not been revealed in detail. More concrete intelligence information is generally given a higher classification as it is inadvisable to disclose classified intelligence that could give the opponent room for maneuver. This means there is a sort of Catch-22 between the persuasiveness of evidence and the intelligence communitys freedom to publicize it. This would certainly apply to evidence proving the unnatural origin and source of COVID-19. In any event, it is hoped that a critical mass of convincing information will soon be reached and brought out in detail.

Possible intelligence footholds could ultimately prove to be a key to answering the big questions. A variety of firms and scientific institutions, mainly in the US, Canada, France, Australia, and Singapore, have been collaborating with the WIV (as well as other bio-labs engaged with coronaviruses in Wuhan). The British intelligence community also likely still maintains significant ties in Hong Kong. With that said, it is by no means assured that all those potential intelligence footholds are willing to fully cooperate with intelligence collectors and forward information, either documented or undocumented.

There is a similar challenge regarding the full sharing of intelligence within NATOs Joint Intelligence, Surveillance and Reconnaissance system, as well as within the Five Eyes intelligence community (the US, Britain, Canada, Australia, and New Zealand). Taiwan, India, South Korea, and Japan might also collect valuable information due to their proximity to and interfaces with China.

Former US presidential adviser Steve Bannon revealed on July 13 that They dont speak with the press yet, but there are people from Wuhans laboratory and from other laboratories who have come to the West and are wrapping up evidence in favor of the Chinese Communist Party. I think people will be shocked. According to him, lab staff have been leaving China and Hong Kong since mid-February and certain defectors are working with the FBI to figure out what happened at Wuhans laboratory. US intelligence, in conjunction with British counterintelligence, is preparing a lawsuit.

If this broad international intelligence process takes shape optimally, an informational critical mass will likely be reached eventually that either clears or identifies the WIV (or a similar lab) as the origin and source of the pandemic. How much of that information will be made public is another issue, considering both its classification and sensitivity and Chinas immense global geostrategic position.

Intelligence is generally proof-free, in scientific and/or juridical terms. Proofs obtained by intelligence systems are certainly desirable and do occur, but substantively, intelligence analysis relies on the tracing and deductive recognition of pertinent evidence, even if circumstantial. At times, this essential characteristic of intelligence analysis can be a great disadvantage, but it is rarely insurmountable.

A proper intelligence estimate will always say There are indicative or indirect data pointing to X rather than There is no proof or hard evidence of X. Broadly speaking, any analytical context that is not merely technical but relies on deduction might ultimately reach the point that evidence, even if circumstantial, allows a solid pragmatic conclusion to be drawn. These assessments are considered valid due to their plausibility, even those that are inferential.

In the case of the origin of the COVID-19 pandemic, because of geopolitical considerations and constraints, this approach will probably not suffice to reach a clear-cut conclusion one way or the other.

Intelligence communities can produce (if not autonomously) scientific judgments as well. The scientific dimension related to SARS-CoV-2 is no less complex, in its way, than the intelligence one. Within the scientific dimension polarity prevails, at least for now.

On one side is the concept that both the origin and the source of SARS-CoV-2 are completely natural, and on the other is the idea that its origin was an engineered virus (whether designed as a bioweapon or for other purposes). Between those two polar concepts lies a wide range of variations and combinations, since viral affinities toward humans (which are exceptional in the case of SARS-CoV-2) can be attained or enhanced in different ways. One hypothesis is that the origin of COVID-19 was a manipulated virus, which, if true, is probably technically unprovable.

Be that as it may, synthetic virology and genetic engineering are not the only ways humans can manipulate the evolutionary course of viruses. It could be that a wild-type virus underwent a spontaneous genetic drift after being administered to or seeded in experimental animals or tissue cultures. This would constitute human intervention or manipulation even though it is neither synthesis nor engineering.

A man-made virus literally means it is wholly synthetic, but there are variations on the term man-made like partly synthesized, hybrid, recombinant, mutant, and so on, all of which are artificial and preplanned. Often, too, evolutionary processes leading to similar viruses take place spontaneously in viruses due to man-induced courses in a lab. Chinese biotechnology has mastered both modes of virus handling.

Two recent scientific observations might be highly significant. One is that humans are not yet clever enough to create a virus as sophisticated as SARS-CoV-2, which means it evolved endogenously within an animal or a tissue culture. The other is that certain components of the virus suggest an interaction with a host immune system, which means it could not have formed solely within a tissue culture. If this is true, the implication is that the virus came into being in an animal, either in nature or in a lab.

One possibility, then, is that a wild-type virus was first propagated repeatedly in human tissue cultures, and the resulting spontaneously upgraded virus was subsequently used to experimentally infect monkeys or ferretsone of which then accidentally infected a person in the lab. (The WIV has long been routinely supplied with rhesus monkeys from the Macaque Breeding Base in Suizhou City.)

It is also possible that a wild-type virus became highly human-adapted through a fully natural genetic process that has not yet been pinpointed, and that it infected a person (either through natural contagion or in a lab where it was held). The probability of such a specific adaptational genetic shift taking place completely in nature has been questioned, though various scientific analyses do rely on it.

There is also always the chance that a wild-type strain that would unequivocally demonstrate natural evolution has not yet been isolated from an animal, or has been isolated but not yet sequenced, or has been sequenced but not published. The point is whether or not the existing genomic data relating to coronaviruses at large are sufficiently representative to be relied on for comparative phylogenetic analyses of the pandemic virus in order to determine whether the genomic difference between the pandemic virus and other coronaviruses is an outcome of a natural evolutionary process or of a non-natural, human-induced technical process.

There have also been observations that the extent (rather than the content) of the genetic shift undergone by the pandemic virus prior to its emergence is discordant with the regular spontaneous course of the natural evolutionary clock.

The timing of Patient Zeros infection and subsequent presentation with the disease is a medical matter, but intelligence can play a role here. For example, information could emerge that verifies that on a certain date a technical mishap occurred in a lab while scientists or technicians were handling monkeys that were infected by a virulent, SARS-like coronavirus. Information could also be gathered that on a certain date a lab technician got ill and was later diagnosed as Patient Zero. Such information may, indeed, have already been obtained and corroborated.

Alternatively, it is conceivable that Patient Zero contracted the virus (or a closely related precursor virus) in a bat cave in Yunnan province and then returned, asymptomatic, to Wuhan. If that is the case, an intermediate animal host species between bat and man is not evolutionarily essential. Still, the fact that nothing of the kind has been reported by China appears to imply that it did not take place.

One hypothesis that might be significant is that the progenitor strain of SARS-CoV-2 was a virus that infected six miners in Mojiang, Yunnan Province in 2012. The mine in which they contracted their illness is known to be a breeding ground of bats infected abundantly with assorted coronaviruses. The virus killed three of the six infected miners.

The virus was isolated at the WIV from specimens taken from the infected miners, as discovered recently by Dr.Jonathan Latham and Dr. Allison Wilson. The details are contained in an unremarkable Chinese masters thesis called Analysis of Six Patients with Severe Pneumonia Caused by Unknown Viruses from Kunming Medical University.

According to the hypothesis of Latham and Wilson, the crucial genetic human-adapted shift the virus underwent (or a major part of it) took place during the infection of one or more of the miners. This shift could have continued while the isolated virus was being investigated at the WIV, prior to the initial COVID-19 outbreak and/or during the infection of Patient Zero in Wuhan. This scenario is consistent with the lab leak theory, whether the virus partially evolved in the WIV or not.

The origin and source of the SARS-CoV-2 virus are still a puzzle, and they need to be explained. The World Health Organization said on July 7:

WHO experts will travel to China to work together with their Chinese counterparts to prepare scientific plans for identifying the zoonotic source of the SARS-CoV-2 virus. The experts will develop the scope and TOR for a WHO-led international mission. Identifying the origin of emerging viral disease has proven complex in past epidemics in different countries. A well planned series of scientific researches will advance the understanding of animal reservoirs and the route of transmission to humans. The process is an evolving endeavor which may lead to further international scientific research and collaboration globally.

Zoonotic refers to an infected animal source, including lab animals.

The WHO system responsible for gathering information about emerging and spreading pathogens worldwide is called Epidemic Intelligence from Open Sources. It remains to be seen how far the WHO investigative mission to China will go (if at all) beyond obtaining open information. It is to be hoped that the mission will conduct a comprehensive, vigorous, and objective investigation and will ignore whatever pressures it might face.

Two WHO experts have gone to China as a first step. Executive director of the WHO Health Emergencies Program Mike Ryan underlined that figuring out the true source of the virus requires detective work that will entail an integrated approach and a lot of hard work.

There are important common denominators between intelligence and science, two paramount spheres that are fundamentally different in both essence and substance. A merging of these spheres would be immensely complicated. They are better used to complement one another. The lines between them are often subtle, with a degree of overlap. It is very much to be hoped that they will be able to work together constructively to reach a critical mass of information on the origin and source of COVID-19.

View PDF

Lt. Col. (res.) Dr. Dany Shoham, a microbiologist and an expert on chemical and biological warfare in the Middle East, is a senior research associate at the Begin-Sadat Center for Strategic Studies. He is a former senior intelligence analyst in the IDF and the Israeli Defense Ministry.

Go here to see the original:

Where Did COVID-19 Really Come From? - besacenter.org

Trending Now: Molecular Scissors Technology Market Detailed Analysis of Current Industry Figures With Forecasts Growth by 2026| Cibus, Thermo Fisher…

LOS ANGELES, United States: QY Research has recently published a report, titled Global Molecular Scissors Technology Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application. The research report gives the potential headway openings that prevails in the global market. The report is amalgamated depending on research procured from primary and secondary information. The global Molecular Scissors Technology market is relied upon to develop generously and succeed in volume and value during the predicted time period. Moreover, the report gives nitty gritty data on different manufacturers, region, and products which are important to totally understanding the market.

Key Companies/Manufacturers operating in the global Molecular Scissors Technology market include: Cibus, Thermo Fisher Scientific, Inc., Merck, Recombinetics, Sangamo Therapeutics, Editas Medicine, Precision BioSciences, Intellia Therapeutics, Inc., Caribou Biosciences, Inc, Cellectis

Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :

https://www.qyresearch.com/sample-form/form/1674037/global-molecular-scissors-technology-market

Segmental Analysis

Both developed and emerging regions are deeply studied by the authors of the report. The regional analysis section of the report offers a comprehensive analysis of the global Molecular Scissors Technology market on the basis of region. Each region is exhaustively researched about so that players can use the analysis to tap into unexplored markets and plan powerful strategies to gain a foothold in lucrative markets.

Global Molecular Scissors Technology Market Segment By Type:

Cas9TALENs and MegaTALsZFNOthers

Global Molecular Scissors Technology Market Segment By Application:

Cell Line EngineeringAnimal Genetic EngineeringPlant Genetic EngineeringOthers

Competitive Landscape

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Molecular Scissors Technology market.

Key companies operating in the global Molecular Scissors Technology market include Cibus, Thermo Fisher Scientific, Inc., Merck, Recombinetics, Sangamo Therapeutics, Editas Medicine, Precision BioSciences, Intellia Therapeutics, Inc., Caribou Biosciences, Inc, Cellectis

Key questions answered in the report:

For Discount, Customization in the Report: https://www.qyresearch.com/customize-request/form/1674037/global-molecular-scissors-technology-market

TOC

1 Market Overview of Molecular Scissors Technology1.1 Molecular Scissors Technology Market Overview1.1.1 Molecular Scissors Technology Product Scope1.1.2 Market Status and Outlook1.2 Global Molecular Scissors Technology Market Size Overview by Region 2015 VS 2020 VS 20261.3 Global Molecular Scissors Technology Market Size by Region (2015-2026)1.4 Global Molecular Scissors Technology Historic Market Size by Region (2015-2020)1.5 Global Molecular Scissors Technology Market Size Forecast by Region (2021-2026)1.6 Key Regions Molecular Scissors Technology Market Size YoY Growth (2015-2026)1.6.1 North America Molecular Scissors Technology Market Size YoY Growth (2015-2026)1.6.2 Europe Molecular Scissors Technology Market Size YoY Growth (2015-2026)1.6.3 China Molecular Scissors Technology Market Size YoY Growth (2015-2026)1.6.4 Rest of Asia Pacific Molecular Scissors Technology Market Size YoY Growth (2015-2026)1.6.5 Latin America Molecular Scissors Technology Market Size YoY Growth (2015-2026)1.6.6 Middle East & Africa Molecular Scissors Technology Market Size YoY Growth (2015-2026)1.7 Coronavirus Disease 2019 (Covid-19): Molecular Scissors Technology Industry Impact1.7.1 How the Covid-19 is Affecting the Molecular Scissors Technology Industry

1.7.1.1 Molecular Scissors Technology Business Impact Assessment Covid-19

1.7.1.2 Supply Chain Challenges

1.7.1.3 COVID-19s Impact On Crude Oil and Refined Products1.7.2 Market Trends and Molecular Scissors Technology Potential Opportunities in the COVID-19 Landscape1.7.3 Measures / Proposal against Covid-19

1.7.3.1 Government Measures to Combat Covid-19 Impact

1.7.3.2 Proposal for Molecular Scissors Technology Players to Combat Covid-19 Impact 2 Molecular Scissors Technology Market Overview by Type2.1 Global Molecular Scissors Technology Market Size by Type: 2015 VS 2020 VS 20262.2 Global Molecular Scissors Technology Historic Market Size by Type (2015-2020)2.3 Global Molecular Scissors Technology Forecasted Market Size by Type (2021-2026)2.4 Cas92.5 TALENs and MegaTALs2.6 ZFN2.7 Others 3 Molecular Scissors Technology Market Overview by Type3.1 Global Molecular Scissors Technology Market Size by Application: 2015 VS 2020 VS 20263.2 Global Molecular Scissors Technology Historic Market Size by Application (2015-2020)3.3 Global Molecular Scissors Technology Forecasted Market Size by Application (2021-2026)3.4 Cell Line Engineering3.5 Animal Genetic Engineering3.6 Plant Genetic Engineering3.7 Others 4 Global Molecular Scissors Technology Competition Analysis by Players4.1 Global Molecular Scissors Technology Market Size (Million US$) by Players (2015-2020)4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Scissors Technology as of 2019)4.3 Date of Key Manufacturers Enter into Molecular Scissors Technology Market4.4 Global Top Players Molecular Scissors Technology Headquarters and Area Served4.5 Key Players Molecular Scissors Technology Product Solution and Service4.6 Competitive Status4.6.1 Molecular Scissors Technology Market Concentration Rate4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data5.1 Cibus5.1.1 Cibus Profile5.1.2 Cibus Main Business and Companys Total Revenue5.1.3 Cibus Products, Services and Solutions5.1.4 Cibus Revenue (US$ Million) (2015-2020)5.1.5 Cibus Recent Developments5.2 Thermo Fisher Scientific, Inc.5.2.1 Thermo Fisher Scientific, Inc. Profile5.2.2 Thermo Fisher Scientific, Inc. Main Business and Companys Total Revenue5.2.3 Thermo Fisher Scientific, Inc. Products, Services and Solutions5.2.4 Thermo Fisher Scientific, Inc. Revenue (US$ Million) (2015-2020)5.2.5 Thermo Fisher Scientific, Inc. Recent Developments5.3 Merck5.5.1 Merck Profile5.3.2 Merck Main Business and Companys Total Revenue5.3.3 Merck Products, Services and Solutions5.3.4 Merck Revenue (US$ Million) (2015-2020)5.3.5 Recombinetics Recent Developments5.4 Recombinetics5.4.1 Recombinetics Profile5.4.2 Recombinetics Main Business and Companys Total Revenue5.4.3 Recombinetics Products, Services and Solutions5.4.4 Recombinetics Revenue (US$ Million) (2015-2020)5.4.5 Recombinetics Recent Developments5.5 Sangamo Therapeutics5.5.1 Sangamo Therapeutics Profile5.5.2 Sangamo Therapeutics Main Business and Companys Total Revenue5.5.3 Sangamo Therapeutics Products, Services and Solutions5.5.4 Sangamo Therapeutics Revenue (US$ Million) (2015-2020)5.5.5 Sangamo Therapeutics Recent Developments5.6 Editas Medicine5.6.1 Editas Medicine Profile5.6.2 Editas Medicine Main Business and Companys Total Revenue5.6.3 Editas Medicine Products, Services and Solutions5.6.4 Editas Medicine Revenue (US$ Million) (2015-2020)5.6.5 Editas Medicine Recent Developments5.7 Precision BioSciences5.7.1 Precision BioSciences Profile5.7.2 Precision BioSciences Main Business and Companys Total Revenue5.7.3 Precision BioSciences Products, Services and Solutions5.7.4 Precision BioSciences Revenue (US$ Million) (2015-2020)5.7.5 Precision BioSciences Recent Developments5.8 Intellia Therapeutics, Inc.5.8.1 Intellia Therapeutics, Inc. Profile5.8.2 Intellia Therapeutics, Inc. Main Business and Companys Total Revenue5.8.3 Intellia Therapeutics, Inc. Products, Services and Solutions5.8.4 Intellia Therapeutics, Inc. Revenue (US$ Million) (2015-2020)5.8.5 Intellia Therapeutics, Inc. Recent Developments5.9 Caribou Biosciences, Inc5.9.1 Caribou Biosciences, Inc Profile5.9.2 Caribou Biosciences, Inc Main Business and Companys Total Revenue5.9.3 Caribou Biosciences, Inc Products, Services and Solutions5.9.4 Caribou Biosciences, Inc Revenue (US$ Million) (2015-2020)5.9.5 Caribou Biosciences, Inc Recent Developments5.10 Cellectis5.10.1 Cellectis Profile5.10.2 Cellectis Main Business and Companys Total Revenue5.10.3 Cellectis Products, Services and Solutions5.10.4 Cellectis Revenue (US$ Million) (2015-2020)5.10.5 Cellectis Recent Developments 6 North America Molecular Scissors Technology by Players and by Application6.1 North America Molecular Scissors Technology Market Size and Market Share by Players (2015-2020)6.2 North America Molecular Scissors Technology Market Size by Application (2015-2020) 7 Europe Molecular Scissors Technology by Players and by Application7.1 Europe Molecular Scissors Technology Market Size and Market Share by Players (2015-2020)7.2 Europe Molecular Scissors Technology Market Size by Application (2015-2020) 8 China Molecular Scissors Technology by Players and by Application8.1 China Molecular Scissors Technology Market Size and Market Share by Players (2015-2020)8.2 China Molecular Scissors Technology Market Size by Application (2015-2020) 9 Rest of Asia Pacific Molecular Scissors Technology by Players and by Application9.1 Rest of Asia Pacific Molecular Scissors Technology Market Size and Market Share by Players (2015-2020)9.2 Rest of Asia Pacific Molecular Scissors Technology Market Size by Application (2015-2020) 10 Latin America Molecular Scissors Technology by Players and by Application10.1 Latin America Molecular Scissors Technology Market Size and Market Share by Players (2015-2020)10.2 Latin America Molecular Scissors Technology Market Size by Application (2015-2020) 11 Middle East & Africa Molecular Scissors Technology by Players and by Application11.1 Middle East & Africa Molecular Scissors Technology Market Size and Market Share by Players (2015-2020)11.2 Middle East & Africa Molecular Scissors Technology Market Size by Application (2015-2020) 12 Molecular Scissors Technology Market Dynamics12.1 Industry Trends12.2 Market Drivers12.3 Market Challenges12.4 Porters Five Forces Analysis 13 Research Finding /Conclusion 14 Methodology and Data Source 14.1 Methodology/Research Approach14.1.1 Research Programs/Design14.1.2 Market Size Estimation14.1.3 Market Breakdown and Data Triangulation14.2 Data Source14.2.1 Secondary Sources14.2.2 Primary Sources14.3 Disclaimer14.4 Author List

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Excerpt from:

Trending Now: Molecular Scissors Technology Market Detailed Analysis of Current Industry Figures With Forecasts Growth by 2026| Cibus, Thermo Fisher...

Longer Looks: Interesting Reads You Might Have Missed – Kaiser Health News

Each week, KHN finds longer stories for you to sit back and enjoy. This week's selections include stories on COVID, eating disorders, PTSD, the art of play, mosquitoes and more.

Politico:Can America Benefit From Covid? Ask 14th-Century FlorenceThe Covid pandemic has wreaked havoc on the U.S. economy. Around 33 million unemployment claims have been made, and hunger stalks millions more Americansand thats aside from the ravages from the disease itself.Yet big disruptions can bring big opportunities. Thinkers have already been considering how the world could emerge better, or smarter, from the Covid plague. And theres real historical precedent for this: The Italian Renaissance may have begun before the 14th-century plague known as the Black Death, but theres a strong case the diseasein both its ravages and the social changes it enabledhelped accelerate its progress, especially in the city of Florence. For a time, Florences economy bounced back with remarkable social mobility, and it became Europes premier center of artistic, cultural and scientific creativity. (Soll, 7/25)

Politico:How Covid-19 Could Give Kim Jong Un A Doomsday WeaponNorth Korea recently surprised the world by announcing it is developing a Covid-19 vaccine, joining a high-stakes race to show off its scientific chops. But experts increasingly believe the famously secretive Kim Jong Un could also have a more nefarious goal in mind: Using the humanitarian crisis to beef up his biological weapons arsenal. North Korea could use this legitimate vaccine aspiration as a way to enhance their biotechnology capability, says Andrew Weber, who was assistant secretary of Defense for nuclear, chemical and biological defense programs during the Obama administration. They could buy equipment from Western or Chinese sources that would be necessary for their vaccine effort, and then next year they could turn around and use it to produce biological weapons. (Ralph, 7/28)

The Wall Street Journal:Foods That Battle Stress During The Coronavirus PandemicAre you anxious? Angry? Feeling depressed?Consider what you eat. For more than a decade, studies have shown that a healthy diethigh in fruits, vegetables, whole grains, fish and other lean proteincan help fight depression. Now, emerging research in the nascent field of nutritional psychiatry suggests that certain foods can help manage a broader range of emotional challenges, such as anxiety, anger and insomnia. And while the most established treatments for mental-health conditions such as depression remain antidepressants and talk therapy, researchers say food can also be a very useful tool. (Bernstein, 7/27)

The Washington Post:Covid-19 Lockdown Nostalgia: It Was A Scary Time, But I Will Miss Our Enforced Family Togetherness.I sent a text to an old college friend in April, inquiring how she was faring under the covid-19 stay-at-home order then in place, and I confided in her that Id be sad to see it end. I liked that everything had slowed down, that for a brief time, Id stepped off the conveyor belt Id been on that made my life feel less meaningful. My friend, a 57-year-old writer in New York, wrote back immediately: Wow. Will not be sad when its over. Its a dark cloud hanging over life, and I feel panicked and dread for people in the restaurant industry, tourism, etc., and the domino effect that will have on us all." (Chesler, 7/26)

The New York Times:I Was A Screen Time Expert. Then The Coronavirus Happened.Before the pandemic, I was a parenting expert. It was a cushy gig. In 2019, I boarded 34 flights. I checked into nice hotels, put on makeup and fitted jewel-toned dresses, strode onto stages large and dinky, and tried to project authoritative calm. I told worried parents about the nine signs of tech overuse, like ditching sleep for screens. I advised them to write a family media contract and trust, but verify, their tweens doings online. While I was on the road, my two daughters were enjoying modest, cute little doses of Peppa Pig and Roblox, in between happily attending school, preschool, after-school activities and play dates, safe in the care of their father, grandmother and our full-time nanny. Now, like Socrates, I know better. I know that I know nothing. (Kamenetz, 7/27)

And other good reads

The New York Times:With Eating Disorders, Looks Can Be DeceivingAppearances, as Im sure you know, can be deceiving. In one all-too-common example, adolescents and young adults with disordered eating habits or outright eating disorders often go unrecognized by both parents and physicians because their appearance defies common beliefs: they dont look like they have an eating problem. One such belief is that people with anorexia always look scrawny and malnourished when in fact they may be of normal weight or even overweight, according to recent research at the University of California, San Francisco. (Brody, 7/27)

The New York Times:Me, My Relationship And PTSDSam and I began the conversation partly in jest. His co-worker had just eloped in Hawaii, and as we scrolled through their photos I gave him an elbow to the ribs and said in a singsong voice, Well, maybe we should go to Hawaii, too! Later we spoke about it in more thoughtful tones, and as it turned out, neither of us had ever been and we both had always wanted to go to Hawaii. I raised my eyebrows and widened my grin. I think we should do it. Not because its time to get married, I added, loudly. But because we have the perfect opportunity to do it. (Conner, 7/25)

The New York Times:The Way We Used To PlayAs kids, my seven siblings and I would run around outside under the night sky, the summer-hard soles of our bare feet the only shoes we needed, playing a game we made up called War. I grew up as one of a legion of kids living in Cedar Hills, Texas. We were also home schooled, so we were weird, and my world was made up of home and church. But in the evening we would play with the neighborhood kids, the ones with backpacks and clean shoes who waved to us on their way to and from school every day. (Lenz, 7/21)

The Atlantic:The Teaching That Works for Traumatized StudentsWhen Ben started flipping desks in the classroom, his teacher Heather Boyle ushered the rest of her first-grade class into the hallway for safety. Things had begun to unravel a few moments earlier, when Benwhose real name isnt being used, to protect his privacystruggled with a math lesson. He crawled under desks, bumping into other childrens legs. When his classmates complained, Boyle asked him to come out. I dont know how to do this stupid math, he screamed. (McKenna, 7/28)

Arizona Republic:The Navajo Nations Wait For Water Persists With Few AnswersThe line forms at the water spigotbefore dawn. In Chevrolets, Fords and Toyotas, men and women of all ages pull up, the beds of their pickups holding plastic tanks and barrels. Each day, all day long, people wait to take the white hose and let the water run into their tanks. Its the only reliable source of clean drinking water they can count on in this part of the Navajo Nation, and they come from miles around to fill up. (James, 7/28)

The New York Times:Why Some Mosquitoes Prefer HumansMosquitoes have been called the deadliest animal in the world: tiny creatures so dangerous that genetic engineering may be necessary to win the battle against them. But not all mosquitoes are equally responsible for devastating the human population by spreading disease. Out of thousands of species, only a few like to bite humans and even within the same species, mosquitoes from different places can have different preferences. Why do some find us irresistible, while others remain unimpressed? To answer that question, a team of Princeton researchers, working with a large network of local collaborators, spent three years driving around sub-Saharan Africa collecting the eggs of Aedes aegypti mosquitoes, which are responsible for Zika, yellow fever and dengue. (Chen, 7/23)

The rest is here:

Longer Looks: Interesting Reads You Might Have Missed - Kaiser Health News

Stryker (SYK) Q2 Earnings and Revenues Surpass Estimates – Yahoo! Voices

Stryker Corporation SYK reported second-quarter 2020 adjusted earnings per share (EPS) of 64 cents, which beat the Zacks Consensus Estimate of 62 cents by 3.2%. However, the bottom line plunged 67.7% year over year owing to the impact of the COVID-19 pandemic.

The Michigan-based medical device company reported revenues of $2.76 billion, which surpassed the Zacks Consensus Estimate by 5.3%. However, the top line declined 24.3% on a year-over-year basis and 23.5% at constant currency (cc).

Revenues in United States came in at $1.97 billion, down 27.1% year over year. International sales declined 16.4% to $798 million.

Orthopaedic: In the quarter under review, revenues in the segment totaled $894 million, down 29.8% year over year. The segments revenues declined 29.3% at cc. The downside can be attributed to weak performance at the Knees, Hips and Trauma and Extremities sub segments.

Stryker Corporation price-consensus-eps-surprise-chart | Stryker Corporation Quote

MedSurg: This segment reported sales of $1.32 billion, down 17.3% year over year. Sales at the segment decreased 16.4% at cc. Per management, the segment declined 29.3% organically in the reported quarter, owing to weak Instruments, Endoscopy and Medical performances.

Neurotechnology and Spine: Sales in the segment amounted to $546 million, down 29.6% year over year and 28.9% at cc. Organically, the segment witnessed a decline of 29.9%. Per management, the downside was can be attributed to a slowdown in procedures in the second quarter in all the neurotech product lines.

In the second quarter, adjusted gross profit totaled $1.58 billion, down 34.1% from the year-ago quarter. Adjusted gross margin was 57.3%, down 850 basis points (bps).

Adjusted operating income amounted to $345 million, down 63.5% from the prior-year quarter. Adjusted operating margin was 12.5%, down 1340 bps.

Story continues

Cash and cash equivalents came in at $6.54 billion, up 50.8% from the year-end 2019.

Cumulative net cash provided by operating activities in the second quarter were $1.21 billion, reflecting an increase of 46.4% from the year-ago period.

Due to the continued uncertainty surrounding the magnitude and duration of the COVID-19 pandemic, and the uncertain timing of global recovery and economic normalization, the company is unable to project the overall impact on its operations and financial results. Consequently, the company hasnt provided third-quarter or full-year 2020 organic sales or earnings outlook.

Stryker exited second-quarter 2020 on a strong note, with both earnings and revenues surpassing the Zacks Consensus Estimate. However, the company witnessed weak performance across its segments. Decline in international sales was also a dampener.

Moreover, Stryker continues to grapple with pricing pressure. Stiff competition in the MedTech space also remains a concern. Further, contraction in both gross and operating margins in the reported quarter remains a headwind.

Although the second quarter results were negatively affected by the pandemic, the company remains committed to continued advancement of its new product pipelines. Per management, the company is poised to capitalize on the broader resumption of deferrable surgeries.

Stryker currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the broader medical space are Thermo Fisher Scientific Inc. TMO, PerkinElmer, Inc. PKI and West Pharmaceutical Services, Inc. WST, each sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of todays Zacks #1 Rank stocks here.

Thermo Fisher reported second-quarter 2020 adjusted EPS of $3.89, beating the Zacks Consensus Estimate by 45.7%. Revenues of $6.92 billion outpaced the consensus mark by 0.1%.

PerkinElmer reported second-quarter 2020 adjusted EPS of $1.57, surpassing the Zacks Consensus Estimate by 68.8%. Revenues of $811.7 million outpaced the consensus mark by 1.3%.

West Pharmaceuticals reported second-quarter 2020 adjusted EPS of $1.25, outpacing the Zacks Consensus Estimate of 91 cents. Revenues of $527.2 million surpassed the consensus estimate by 6.9%.

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free reportStryker Corporation (SYK) : Free Stock Analysis ReportPerkinElmer, Inc. (PKI) : Free Stock Analysis ReportThermo Fisher Scientific Inc. (TMO) : Free Stock Analysis ReportWest Pharmaceutical Services, Inc. (WST) : Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment Research

Read more here:

Stryker (SYK) Q2 Earnings and Revenues Surpass Estimates - Yahoo! Voices

Top Shorts In The Last Eight Years That Paid Off Big Time – Yahoo Finance

Its incredibly difficult to make big money shorting stocks. You need a strong conviction in your bets. You need to have a firm belief that something is cooking in the company that most people overlook or choose to ignore. Those shorting stocks during theCOVID-19 pandemichave made more than $50 billion in profits.

Here we take a look at the top shorts of each year between 2013 and 2020. The list is based on data fromActivist Insight Shorts. Josh Black of Activist Insight has given double credit where two short sellers were first and second on the same idea, though their campaign returns might be slightly different.

Short selling is when you bet against astockand profit when it falls. Short sellers borrow shares from investors and then sell them at market price. They expect the stock to decline by a specified future date (the expiration date). If/when the stock tumbles, the short seller buys it back at ridiculously low prices to return to theinvestorfrom whom they had borrowed. The short seller pockets the difference. But sometimes shorting backfires when the stock in question skyrockets.

These are the top shorts between 2013 and 2020 (so far):

Want more short ideas? Check out our upcoming virtual conference with top shortsellers on August 11th.

Short seller The Street Sweeperreleasedan explosive report on Miller Energy Resources in 2011, questioning its accounting practices. The East Tennessee-based oil and gas exploration company slammed the report. Miller CEO Scott Boruff said The Street Sweeper was using deceptive and manipulative tactics to bring down the stock. The Street Sweeper announced in December 2013 that it was shorting Miller Energy. The campaign return stood at a staggering 99.92%. TheSecurities and Exchange Commission(SEC) found that Miller and its executives had "violated the federal securities laws by materially overstating the value of certain oil and gas assets acquired in Alaska on its financial statements."

Apptigo was a technology company engaged in the design and development of smartphone apps. It was the company behind the SCORE match-making app. Short seller GeoInvesting (FG Alpha Management) accused that the company's leadership was engaged in pumping up the stock around the same time Apptigo was hailed as "The #1 Mobile App Tech Stock of 2014." GeoInvesting's short bet gave 99.96% in campaign returns.

Headquartered in Irving, Texas, Adeptus operates free-standing emergency rooms. Short seller Long-Short Value announced in September 2015 that it was shorting the stock. By early 2016, Adeptus had thehighestshort interest among the US-listedstocks. The healthcare companyfiled for Chapter 11 bankruptcyin 2017 amid soaring debt and falling demand. Adeptusemergedfrom the bankruptcy a few months later after completing its financial restructuring. The campaign returned a handsome 98.87%.

Tech Pro Technology is a Hong Kong-based manufacturer of LED lighting products and accessories. In June 2016, GeoInvesting announced that it was shorting the stock. GeoInvesting said at theSohn Conference Hong Kongthat the stock was "grossly overvalued" and "detached from the reality." A little over a month later, Glaucus Research Group announced that it was also shorting Tech Pro Technology. Both short sellers generated about 96.3% in campaign returns.

New York-based Helios and Matheson was a data analytics company. It acquired a controlling stake in MoviePass, a movie subscription service, in 2017. MoviePass was burning cash at an unprecedented pace. The Street Sweeper announced in September 2017 that it was shorting Helios and Matheson. Its shares fell from $38 in October 2017 to $0.21 in July 2018. The company said in January 2020 that it wouldfile for Chapter 7 bankruptcyand liquidate its assets.

Orchids Paper Products is a manufacturer of consumer tissue products. In 2012, Forbes magazine named it among "America's Best Small Companies." The company started facing financial challenges in 2016 due to rising input costs and increasing competition. But the CEO's compensation remainedmuch higherthan the industry average. White Diamond Research announced in December 2018 that it was shorting the stock with 100% downside target. The campaignreturned 99.7%.

Story continues

Helius is a neurotechnology company focused on neurological wellness. In January 2019, White Diamond Researchpublished an articleon Seeking Alpha claiming Helius' only product was an "ineffective device." The short seller also alleged that Helius Medical's founders had "a history of questionable marketing practices." White Diamond evensent a letterto the USFDA, urging them to reject the company's marketing application for the PoNS device. The campaign returned 94.93%.

Luckin Coffee Inc. was hailed as the Starbucks of China. Its growth rate had shocked the Wall Street. In January 2020, Muddy Waters Researchpublished a scathing reportsaying Luckin Coffee was a "broken business" engaged in an accounting fraud. Just days later, J Capital Research confirmed that it was also shorting the stock. When Muddy Waters and J Capital both are shorting a stock, you wouldn't want to be on the other side of the table. After its fraudulent accounting practices came to light, the Chinese company fired its CEO and COO, and Nasdaq halted the trading of its shares.

Want more short ideas? Check out our upcoming virtual conference with top shortsellers on August 11th.

Video: Top 5 Stocks Among Hedge Funds

At Insider Monkey we scour multiple sources to uncover the next great investment idea. We go through lists like the 10most profitable companiesin the world to pick the best large-cap stocks to buy. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. If you want to find out the best healthcare stock to buy right now, you can watch our latesthedge fund manager interview here. You can subscribe to our free enewsletter below to receive our stories in your inbox:

See the article here:

Top Shorts In The Last Eight Years That Paid Off Big Time - Yahoo Finance